Investors Chronicle Fund Awards 2013

Deutsche Asset & Wealth Management Xtrackers ETFs have won three out of five exchange-traded product awards at the 2013 Investors Chronicle Fund Awards. The Investors Chronicle is part of the Financial Times group and has a large readership of private investors. With the exception of the innovation award, which was made on the basis of a subjective assessment of innovation by the Investors Chronicle editorial team, winners were chosen based on a number of parameters which aimed to gauge overall product quality. Using information from independent data provider Lipper, the assessment criteria included analysis of tracking difference across several time periods and overall costs, while the Investors Chronicle also took into consideration the quality of investor communication.

Winner – Best Exchange Traded Product for UK Equity exposure:
db x-trackers FTSE 100 ETF

This is the second year in a row that the db x-trackers FTSE 100 UCITS ETF has been named Best ETP for UK Equity Exposure, in recognition of its low cost, tracking difference across several periods and high standards of investor communication.

Best Exchange Traded Product for US Equity exposure:
db x-trackers MSCI USA Index UCITS ETF

The Recognising its competitiveness in terms of costs and tracking difference across, among other criteria, the db x-trackers MSCI USA Index UCITS ETF has been named the best product for investors wishing to take exposure to United States equities.

Most Innovative Exchange Traded Product Award:
db x-trackers CSI300 UCITS ETF

In recognition of innovation in providing access to China's domestic A-shares market, the db x-trackers CSI300 UCITS ETF has been awarded the prestigious innovation award.